Jan. 31 at 3:47 PM
$MCK With consistent revenue growth, massive free cash flow, and favorable analyst sentiment, McKesson Corporation (NYSE:MCK) is emerging as a compelling healthcare investment opportunity. https://biotechhealthx.com/biotech-news/wall-street-sees-nearly-15-upside-in-mckesson-corporation-mck-heres-why/